NanoViricides Inc. (NNVC): NNVC: NSLIJ Scientists to Present EKC-Ci...

Reply Private New

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 04/21/2009 7:04:51 AM

Tuesday, April 21, 2009 7:04:51 AM

NNVC: NSLIJ Scientists to Present EKC-Cide(TM) Study Results at the GTC-Bio Conference on Ocular Diseases and Drug Discovery

http://www.marketwatch.com/News/Story/Story.aspx?guid={6FC26692-5094-4223-89D9-528034E92F92}&siteid=nbsh

Keep Last Read

Replies (4) Next 10 Prev Next

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM

InvestorsHub NewsWire

Only $200 per official company press release!